IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Chronic Focal Encephalitis
California Pacific Medical Center Research Institutemonoclonal_antibodyPhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
6 Active assets in the Chronic Focal Encephalitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
HUMAN IMMUNOGLOBULINS University Hospital, Bonn | Phase 2/3 | B |
TACROLIMUS University Hospital, Bonn | Phase 2/3 | B |
Evomela Fred Hutchinson Cancer Center | Phase 2 | CCC |
Anti-Thymoglobulin, Rabbit Fred Hutchinson Cancer Center | Phase 2 | CCC |
ETOPOSIDE Fred Hutchinson Cancer Center | Phase 2 | CCC |
PREDNISONE TABLETS Fred Hutchinson Cancer Center | Phase 2 | CCC |
Cytosin-Arabinosid Fred Hutchinson Cancer Center | Phase 2 | CCC |
CARMUSTINE Fred Hutchinson Cancer Center | Phase 2 | CCC |
Same molecule, other indications
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →